Shoreline Biosciences
Latest round
- Series B
Last raised
- Oct 2021
Total raised
- $183M
Investors
- 18
About Shoreline Biosciences
Shoreline Biosciences, founded in 2020 in San Diego, US, is focused on developing cellular immunotherapy solutions.Shoreline Biosciences specializes in innovative cellular immunotherapy solutions, primarily focusing on iPSC-derived natural killer cells (iNK) and macrophages (iMACs). Their core offerings are designed to provide safe, effective, and affordable therapies for patients with unmet medical needs, utilizing advanced techniques in iPSC differentiation, genetic engineering, and immune cell biology. The company's iNK and iMACs platforms facilitate the development of homogeneous and scalable off-the-shelf products, targeting various therapeutic applications such as cancer treatment and immune system enhancement.Shoreline Biosciences generates revenue primarily through partnerships and collaborations with healthcare providers, research institutions, and pharmaceutical companies. Transactions typically occur on a B2B basis, involving agreements for the supply of their cellular immunotherapy products for clinical trials, research purposes, or commercial applications. Expanding into international markets, Shoreline aims to increase its presence in Asia and Europe by 2023, targeting collaborations with key healthcare providers and institutions.
Who invested in Shoreline Biosciences
18 investors across 2 rounds
See all investors in Shoreline Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shoreline Biosciences
Who invested in Shoreline Biosciences?
Shoreline Biosciences has 18 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shoreline Biosciences raised?
Shoreline Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Shoreline Biosciences last raise money?
Shoreline Biosciences's most recent round on record is a Series B, in Oct 2021.
What does Shoreline Biosciences do?
Shoreline Biosciences, founded in 2020 in San Diego, US, is focused on developing cellular immunotherapy solutions.
Where is Shoreline Biosciences headquartered?
Shoreline Biosciences is headquartered in San Diego, US.
Which VCs invest in companies like Shoreline Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Shoreline Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Shoreline Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.